Stem Cell Treatments for Chronic Bronchitis in 2013 |

Overview: What Are Stem Cell Treatments for Chronic Bronchitis?

Stem cell treatments for chronic bronchitis are one of the latest advancements in chronic bronchitis treatments available today, and are being utilized in clinical settings around the world. Once considered an alternative form of treatment for chronic bronchitis and other forms of lung disease, stem cell therapies for chronic bronchitis are becoming increasingly more common as they provide consistent positive results for patients suffering from mild, moderate, and severe forms of chronic bronchitis. Stem cells and other forms of regenerative medicine are helping people improve their quality of life and breathe easier.

Adipose (Fat-Derived) Stem Cell Procedure & Venous (Blood-Derived) Stem Cell Procedure for Chronic Bronchitis

Lung Institute utilizes adult autologous stem cells, derived from the patients own body, for the adipose (fat-derived) stem cell procedure and the venous (blood-derived) stem cell procedure. These stem cells are extracted, isolated, and immediately reintroduced to the affected lung tissue, where they then divide and replicate into healthy cells specialized to that tissue. The use of autologous stem cells in transplantation is considered to be more reliable than stem cells from another individual as there is a much lower probability of rejection. Both adipose stem cells and venous stem cells have shown anti-inflammatory properties beneficial to patients with lung disease.

Adult stem cells have the ability to self-renew indefinitely, meaning they have the capability to divide many times and specialize in the repair of damaged organs while still sustaining the original undifferentiated cell. The adipose procedure is always performed in conjunction with the venous procedure, while the venous procedure may be chosen to be performed on its own depending on the nature of the patients condition and health history.

Lung Institute does not use any type of embryonic or fetal stem cells in their procedures.

Autologous Mesenchymal Stem Cells

During the adipose procedure human mesenchymal stem cells (hMSCs) are extracted from the patients adipose tissue. hMSCs are immune-modulatory and versatile due to their secreted bioactive molecules, giving them anti-inflammatory and regenerative properties. Because of this, these highly specialized cells have the potential orchestrate the complex reparative processes needed to restore diseased lung tissues. Human mesenchymal stem cells are not only utilized in the restoration of damage lung tissue, but are also capable of regenerating into multiple phenotypes, including cells capable of forming bone, cartilage, muscle, marrow, tendon/ligament, adipocytes (adipose tissue) and connective tissue.

As a result of hMSCs intrinsic capability to differentiate into various phenotypes of mature cells while secreting cytokines and natural growth factors at the site of tissue damage, they have significant therapeutic capacity in sufferers of chronic bronchitis.

In the adipose procedure, following the extraction of hMSCs from fat tissue, hematopoetic stem cells are also extracted through the use of an IV. Both types of stem cells are then washed and separated in the lab. They are then immediately inserted into the patients body intravenously once again for the molecular cueing of regenerative pathways in damaged lung tissues.

See the rest here:
Stem Cell Treatments for Chronic Bronchitis in 2013 |